Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Cariou

Showing results (141-150 of 311) with videos related to

Pageof 32
Sort By:
Diabetes Research and Clinical Practice|February 12, 2021
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO studyBertrand Cariou, Matthieu Pichelin, Thomas Goronflot, et al.
BMC Cardiovascular Disorders|September 22, 2014
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trialsHelen M Colhoun, Jennifer G Robinson, Michel Farnier, et al.
JAMA Cardiology|March 28, 2026
Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical TrialSteven E Nissen, Kathy Wolski, David D'Alessio, et al.
Diabetes Research and Clinical Practice|May 13, 2015
Clinical use of insulin degludecJiten Vora, Bertrand Cariou, Marc Evans, et al.
JAMA Pediatrics|February 5, 2024
Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical TrialRaul D Santos, Albert Wiegman, Sonia Caprio, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 13, 2014
Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot studySara De Giorgi, Vanessa Campos, Leonie Egli, et al.
European Journal of Preventive Cardiology|September 1, 2022
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemiaMartine Paquette, Alain Carrié, Sophie Bernard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 30, 2023
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial HypercholesterolemiaMartine Paquette, Bertrand Cariou, Sophie Bernard, et al.
Disease Models & Mechanisms|November 21, 2015
Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemiaKarim Si-Tayeb, Salam Idriss, Benoite Champon, et al.
Surgery|November 7, 2023
Do men improve their bone mineral density 1 year after parathyroidectomy for primary hyperparathyroidism? Results of a prospective studySamuel Frey, Pascale Guillot, Matthieu Wargny, et al.
Pageof 32

Showing results (141-150 of 311) with videos related to

Sort By:
Pageof 32
Diabetes Research and Clinical Practice|February 12, 2021
Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: Results from the CORONADO studyBertrand Cariou, Matthieu Pichelin, Thomas Goronflot, et al.
BMC Cardiovascular Disorders|September 22, 2014
Efficacy and safety of alirocumab, a fully human PCSK9 monoclonal antibody, in high cardiovascular risk patients with poorly controlled hypercholesterolemia on maximally tolerated doses of statins: rationale and design of the ODYSSEY COMBO I and II trialsHelen M Colhoun, Jennifer G Robinson, Michel Farnier, et al.
JAMA Cardiology|March 28, 2026
Cardiorenal Outcomes With Tirzepatide Compared With Dulaglutide in Patients With Diabetes and Cardiovascular Disease: A Post Hoc Analysis of the SURPASS-CVOT Randomized Clinical TrialSteven E Nissen, Kathy Wolski, David D'Alessio, et al.
Diabetes Research and Clinical Practice|May 13, 2015
Clinical use of insulin degludecJiten Vora, Bertrand Cariou, Marc Evans, et al.
JAMA Pediatrics|February 5, 2024
Alirocumab in Pediatric Patients With Heterozygous Familial Hypercholesterolemia: A Randomized Clinical TrialRaul D Santos, Albert Wiegman, Sonia Caprio, et al.
Clinical Nutrition (Edinburgh, Scotland)|October 13, 2014
Long-term effects of Roux-en-Y gastric bypass on postprandial plasma lipid and bile acids kinetics in female non diabetic subjects: A cross-sectional pilot studySara De Giorgi, Vanessa Campos, Leonie Egli, et al.
European Journal of Preventive Cardiology|September 1, 2022
Effect of the LDL receptor mutation type on incident major adverse cardiovascular events in familial hypercholesterolaemiaMartine Paquette, Alain Carrié, Sophie Bernard, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 30, 2023
Increased FH-Risk-Score and Diabetes Are Cardiovascular Risk Equivalents in Heterozygous Familial HypercholesterolemiaMartine Paquette, Bertrand Cariou, Sophie Bernard, et al.
Disease Models & Mechanisms|November 21, 2015
Urine-sample-derived human induced pluripotent stem cells as a model to study PCSK9-mediated autosomal dominant hypercholesterolemiaKarim Si-Tayeb, Salam Idriss, Benoite Champon, et al.
Surgery|November 7, 2023
Do men improve their bone mineral density 1 year after parathyroidectomy for primary hyperparathyroidism? Results of a prospective studySamuel Frey, Pascale Guillot, Matthieu Wargny, et al.
Pageof 32